Join our NAD+ study Be a part of groundbreaking NAD+ research. Essential for life, your body makes NAD+ naturally, and it can have profound effects on your health and lifespan. This study takes a deep look at thousands of measurements in your blood to see what supplementing...
The primary objective of this study is to assess the efficacy of botulinum toxin injections to the upper limb muscles for essential tremor. In the first part of the study, only one arm will be injected with either botulinum toxin or placebo and then followed up...
We are looking for adults age 65 and older who are interested in healthy eating. The primary purpose of this study is to evaluate a new mobile intervention that allows people to track their diet and receive personalized recommendations. If you are interested and want to...
In the United States (US), reports document over 47 million cases and more than 760,000 deaths, costing nearly $17 trillion in 2020 (Centers for Disease Control [CDC], 2020; Cutler & Summers, 2020). While the magnitude of the problem remains unknown, knowing the sheer number of...
This study is completely online and via smartphone and will last 6 weeks. All participants will receive a digital (app-based) treatment for anxiety and worry and will be asked to use the app for 6-weeks. The study will also involve completing 3 phone calls with a study...
For most individuals, active participation in daily life requires the ability to follow conversations in crowded acoustic environments. Most typically-functioning young individuals have little trouble communicating in noisy environments. However, these processes are susceptible to disruption or breakdown at every level of the ascending auditory...
To evaluate the efficacy of troriluzole as adjunctive therapy compared to placebo in subjects with OCD who have had an inadequate response to their current OCD treatment based on the change in their Y-BOCS score To assess the safety and tolerability of troriluzole, relative to placebo,...
To evaluate the efficacy, safety, and tolerability of AVP-786 compared to placebo, for the treatment of agitation in patients with dementia of the Alzheimer's type To evaluate the effects of AVP-786 compared to placebo on neuropsychiatric symptoms To evaluate the effects of AVP-786 compared to placebo on...
To evaluate the clinical efficacy of ATH-1017 To determine the safety and tolerability of ATH-1017 To evaluate the clinical efficacy of ATH-1017 separately on: (1) cognition and (2) clinical global impression of change To evaluate the effect of ATH-1017 on activities of daily living To determine the plasma pharmacokinetic (PK) profile...
To determine if treatment with SAGE-217 reduces depressive symptoms in women with postpartum depression (PPD) compared to placebo. To determine if treatment with SAGE-217 reduces anxiety symptoms compared to placebo. To assess self-report of depressive symptoms To evaluate the safety and tolerability of SAGE-217 This is a PHASE 3...
